Filed: 11/14/2025ACC: 0001104659-25-112503
📋 What this filing means
FORESITE CAPITAL MANAGEMENT V, LLC filed this quarterly 13F‑HR report disclosing 6 equity positions with a total reported market value of $108.74M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
6
Positions
$108.74M
Total AUM (reported)
7.92M
Total Shares
Allocation by class
COM$93.25M85.8%
COM CL A$15.49M14.2%
Portfolio Concentration
Top 3$83.27M76.6%
4–10$25.48M23.4%
Top 3 weight
76.6%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 7.92M
Sole
Full voting authority
7.92M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole6
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings6
Rows:
CG Oncology, Inc.
SOLEShares1M
TypeSH
Market value$40.44M
37.19%
Sole
1M
Shared
0.00
None
0.00
ALUMIS INC.
SOLEShares5.78M
TypeSH
Market value$23.06M
21.21%
Sole
5.78M
Shared
0.00
None
0.00
Disc Medicine, Inc.
SOLEShares299.07K
TypeSH
Market value$19.76M
18.17%
Sole
299.07K
Shared
0.00
None
0.00
Hims & Hers Health, Inc.
SOLEShares273.15K
TypeSH
Market value$15.49M
14.25%
Sole
273.15K
Shared
0.00
None
0.00
Lyell Immunopharma, Inc.
SOLEShares477.08K
TypeSH
Market value$7.75M
7.12%
Sole
477.08K
Shared
0.00
None
0.00
Maze Therapeutics, Inc.
SOLEShares86.29K
TypeSH
Market value$2.24M
2.06%
Sole
86.29K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
CG Oncology, Inc.SOLE | COM | 1M | SH | $40.44M 37.19% | 1M | 0.00 | 0.00 |
ALUMIS INC.SOLE | COM | 5.78M | SH | $23.06M 21.21% | 5.78M | 0.00 | 0.00 |
Disc Medicine, Inc.SOLE | COM | 299.07K | SH | $19.76M 18.17% | 299.07K | 0.00 | 0.00 |
Hims & Hers Health, Inc.SOLE | COM CL A | 273.15K | SH | $15.49M 14.25% | 273.15K | 0.00 | 0.00 |
Lyell Immunopharma, Inc.SOLE | COM | 477.08K | SH | $7.75M 7.12% | 477.08K | 0.00 | 0.00 |
Maze Therapeutics, Inc.SOLE | COM | 86.29K | SH | $2.24M 2.06% | 86.29K | 0.00 | 0.00 |